Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RG's Letter. I think his followup letter was a good strategic idea.

Are you insinuating that the shareholders should not ask tough questions and scrutinize this company???? and you wonder why some are questioning who you are and why you are here???

I never ever wrote that the Final Rejection was "the end of licensing" and you know this very well. I wrote that the Finnal Rejection was certainly not "much ado about nothing" (which you stated) and the Final Rejection was a "serious set-back" as anyone with an ounce of common sense would conclude. You seem to want to make it out to be a "non-event". Needless to say, this is very puzzling.



Share
New Message
Please login to post a reply